Your browser version may not work well with NCBI's Web applications. More information here...
1: Br J Dermatol. 1999 Oct;141(4):725-7.Click here to read Links

Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin.

Darvay A, Acland KM, Russell-Jones R.

Department of Dermatology, Ealing Hospital, Uxbridge Road, Southall, Middlesex UB1 3HW, UK. amritdar@btinternet.com

We report two patients with severe ulcerated necrobiosis lipoidica (NL) who responded to cyclosporin. One patient had suffered persistent ulceration for a period of 7 years and the other had NL of recent onset. In both cases, ulceration healed completely after 4 months of therapy, and both patients have remained free of ulceration since discontinuing therapy. The possible mode of action of cyclosporin in the context of this debilitating disease is discussed.

PMID: 10583126 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Cyclosporine (Neoral® , Sandimmune® , Gengraf® )

    Cyclosporine and cyclosporine (modified) are used with other medications to prevent transplant rejection (attack of the transplanted organ by the immune system of the person who received the organ) in people who have rec...

  • Source: AHFS Consumer Medication Information